Fermenta Biotech gets EIR for Gujarat manufacturing facility

06 Jul 2024 Evaluate

The United States Food and Drug Administration (USFDA) has issued an Establishment Inspection Report (EIR) to Fermenta Biotech’s manufacturing facility situated at Dahej, Gujarat, India with no observations as to any significant objectionable conditions, and the inspection has been successfully ‘closed’ by the USFDA.

Fermenta Biotech (formerly known as DIL) is engaged in the business of research support services through their subsidiary Research Support International (RSIL), manufacture and marketing of enzymes and chemicals through their subsidiary Fermenta Biotech (FBL).

Fermenta Biotech Share Price

330.95 4.10 (1.25%)
22-Nov-2024 12:00 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1774.50
Dr. Reddys Lab 1204.20
Cipla 1483.05
Lupin 2055.30
Zydus Lifesciences 944.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.